CN108524948B - 一种透明质酸衍生化的非甾体抗炎抗癌药物及其制备方法和应用 - Google Patents
一种透明质酸衍生化的非甾体抗炎抗癌药物及其制备方法和应用 Download PDFInfo
- Publication number
- CN108524948B CN108524948B CN201810766897.7A CN201810766897A CN108524948B CN 108524948 B CN108524948 B CN 108524948B CN 201810766897 A CN201810766897 A CN 201810766897A CN 108524948 B CN108524948 B CN 108524948B
- Authority
- CN
- China
- Prior art keywords
- hyaluronic acid
- inflammatory
- drug
- steroidal anti
- anticancer drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810766897.7A CN108524948B (zh) | 2018-07-13 | 2018-07-13 | 一种透明质酸衍生化的非甾体抗炎抗癌药物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810766897.7A CN108524948B (zh) | 2018-07-13 | 2018-07-13 | 一种透明质酸衍生化的非甾体抗炎抗癌药物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108524948A CN108524948A (zh) | 2018-09-14 |
CN108524948B true CN108524948B (zh) | 2020-03-10 |
Family
ID=63488216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810766897.7A Active CN108524948B (zh) | 2018-07-13 | 2018-07-13 | 一种透明质酸衍生化的非甾体抗炎抗癌药物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108524948B (zh) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005066214A1 (ja) * | 2004-01-07 | 2005-07-21 | Seikagaku Corporation | ヒアルロン酸誘導体及びそれを含む薬剤 |
IE20060565A1 (en) * | 2006-07-28 | 2008-02-06 | Eurand Pharmaceuticals Ltd | Drug delivery system based on regioselectively amidated hyaluronic acid |
CN107096036B (zh) * | 2017-04-12 | 2020-01-14 | 武汉理工大学 | 一种pH敏感型透明质酸-多柔比星纳米前药的制备方法及其应用 |
-
2018
- 2018-07-13 CN CN201810766897.7A patent/CN108524948B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN108524948A (zh) | 2018-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101594552B1 (ko) | 알킬화된 반합성 글리코사미노글리코산 에테르 및 이의 제조 및 사용 방법 | |
Morris et al. | Polysaccharide drug delivery systems based on pectin and chitosan | |
Maxwell et al. | Pectin–an emerging new bioactive food polysaccharide | |
Lyu et al. | Natural polysaccharides with different conformations: Extraction, structure and anti-tumor activity | |
Lee et al. | Esterase-sensitive cleavable histone deacetylase inhibitor-coupled hyaluronic acid nanoparticles for boosting anticancer activities against lung adenocarcinoma | |
Zhao et al. | Preparation of low-molecular-weight polyguluronate sulfate and its anticoagulant and anti-inflammatory activities | |
US8445465B2 (en) | Glycol chitosan derivative, preparation method thereof and drug delivery system comprising the same | |
JP2006516988A (ja) | 持続した薬物放出またはムコ粘着のための活性剤およびキトサンを含む製薬組成物 | |
AU2019310656B2 (en) | Highly sulfated fucans for the treatment of fibrous adhesions | |
Chen et al. | Targeted delivery of methotrexate by modified yeast β-glucan nanoparticles for rheumatoid arthritis therapy | |
CN108524948B (zh) | 一种透明质酸衍生化的非甾体抗炎抗癌药物及其制备方法和应用 | |
CN108912245B (zh) | 一种具有靶向性和抗炎活性的氟化透明质酸衍生物及其制备方法和应用 | |
Qiu et al. | Aminated β-Glucan with immunostimulating activities and collagen composite sponge for wound repair | |
JP5866693B2 (ja) | 大腸癌の前癌病変発生抑制剤及び方法 | |
Huang et al. | A functional polysaccharide from Eriobotrya japonica relieves myocardial ischemia injury via anti-oxidative and anti-inflammatory effects | |
Li et al. | Preparation of a novel glucuronomannan from Auricularia auricala and its immunological activity | |
CN106573013B (zh) | 用于治疗关节炎的包含石莼多糖的粘性补充剂组合物 | |
WO2022140850A1 (en) | Immune- stimulating compounds linked to glycogen-based polysaccharide nanoparticles for sensitizing cancer cells to a chemotherapeutic drug | |
WO2021128253A1 (zh) | 一种糖胺聚糖衍生物及其应用 | |
JP2011132369A (ja) | 分岐キトサン誘導体 | |
Vildanova et al. | Modification of Chitosan and Hyaluronic Acid to Obtain Sustainable Hydrogels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Gao Yin Inventor after: Wang Bo Inventor after: Guo Jianfeng Inventor after: Qiu Pengyu Inventor after: Tong Jie Inventor after: Bai Ruifeng Inventor before: Gao Yin Inventor before: Guo Jianfeng Inventor before: Qiu Pengyu Inventor before: Tong Jie Inventor before: Bai Ruifeng Inventor before: Wang Bo |
|
GR01 | Patent grant | ||
GR01 | Patent grant |